C07H 7/00
Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
C07H7/00 (Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond) appears on 560 US grants and 574 published applications in this corpus.
Search patents in C07H- Granted patents
- 560
- Published applications
- 574
- Assignees
- 381
- Inventors
- 1,609
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 3 | 0 |
| 1984 | 5 | 0 |
| 1985 | 3 | 0 |
| 1986 | 7 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 6 | 0 |
| 1993 | 10 | 0 |
| 1994 | 7 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 17 | 0 |
| 1999 | 8 | 0 |
| 2000 | 9 | 0 |
| 2001 | 7 | 1 |
| 2002 | 15 | 17 |
| 2003 | 20 | 12 |
| 2004 | 5 | 17 |
| 2005 | 8 | 23 |
| 2006 | 11 | 32 |
| 2007 | 6 | 16 |
| 2008 | 11 | 21 |
| 2009 | 17 | 24 |
| 2010 | 23 | 30 |
| 2011 | 21 | 36 |
| 2012 | 22 | 21 |
| 2013 | 28 | 19 |
| 2014 | 15 | 29 |
| 2015 | 25 | 30 |
| 2016 | 16 | 21 |
| 2017 | 11 | 22 |
| 2018 | 19 | 22 |
| 2019 | 20 | 23 |
| 2020 | 25 | 29 |
| 2021 | 24 | 28 |
| 2022 | 18 | 17 |
| 2023 | 20 | 27 |
| 2024 | 16 | 29 |
| 2025 | 10 | 18 |
| 2026 | 12 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Carbohydrate derivatives and kits for cell surface labeling15 Sep 2026US 12,734,242 B2Institute of Organic Chemistry and Biochemistry AS Cr, V. V. I.
- Antiviral compounds and methods of making and using the same1 Sep 2026US 12,723,057 B2Gilead Sciences, Inc.
- Advanced glycation end product analogues18 Aug 2026US 12,709,630 B2Phytoquest Limited
- ASGPR-binding compounds for the degradation of extracellular proteins30 Jun 2026US 12,667,620 B2Avilar Therapeutics, Inc.
- Catalysts and their uses in one-pot diastereoselective synthesis of remdesivir30 Jun 2026US 12,667,832 B2Academia Sinica
- Method for purifying chrysomycin a from fermentation products of streptomyces8 Oct 2026US 2026/0308195 A1Zhejiang University of Technology
- Sodium -glucose contransporter 2 inhibitor derivative6 Aug 2026US 2026/0226090 A1Anxo Pharmaceutical Co., Ltd.
- Lipid nanoparticles18 Jun 2026US 2026/0165979 A1Kyushu University, National University Corporation
- Antiviral prodrugs, intermediate-and long-acting formulations and methods4 Jun 2026US 2026/0151415 A1The Regents of the University of California
- C-mannoside compounds useful for the treatment of urinary tract infections4 Jun 2026US 2026/0152519 A1Fimbrion Therapeutics, Inc.
Most cited
By later US patents
- Bis-modified bicyclic nucleic acid analogs253US 7,666,854 B2Isis Pharmaceuticals, Inc. · 2010
- C-aryl glucoside SGLT2 inhibitors and method184US 6,515,117 B2Bristol-Myers Squibb Company · 2003
- Bis-modified bicyclic nucleic acid analogs125US 8,088,746 B2Isis Pharmaceuticals, Inc. · 2012
- 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment116US 7,973,013 B2Gilead Sciences, Inc. · 2011
- Methods of producing C-aryl glucoside SGLT2 inhibitors88US 7,375,213 B2Bristol-Myers Squibb Company · 2008